Tech Company Financing Transactions
Theseus Pharmaceuticals Funding Round
Foresite Capital, Adage Capital Management and Boxer Capital invested in a $100 million Series B venture round for Theseus Pharmaceuticals. This venture round was announced on 4/14/2021.
Transaction Overview
Company Name
Announced On
4/14/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
210 Broadway St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Medical Officer
David Kerstein
Chief Scientific Officer
Victor Rivera
Chief Technical Officer
David Dalgarno
Co-Founder
William Shakespeare
Vice President
Wei-Sheng Huang
Browse more venture capital transactions:
Prev: 4/14/2021: Jaguar Gene Therapy venture capital transaction
Next: 4/14/2021: Hazel Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs